Editorial: Cryptococcosis and 5-fluorocytosine.
D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D003453:Cryptococcosis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D005437:Flucytosine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D051381:Rats
D000666:Amphotericin B; D003596:Cytosine; D005437:Flucytosine